期刊文献+

N-[2-(4-特戊酰氧基苯磺酰胺基)苯甲酰基]甘氨酸苄酯的合成 被引量:1

Synthesis of N-[2-(4-trimethylacetoxyb enzenesulphonamino) benzoyl]glycine benzyl ester
下载PDF
导出
摘要 目的合成西维来司钠(sivelestatsodium)的关键中间体N-[2-(4-特戊酰氧基苯磺酰胺基)苯甲酰基]甘氨酸苄酯(1)。方法先以特戊酸、氯化亚砜、对羟基苯磺酸为原料,经酯化、苯磺酸成酰氯得到对位特戊酰氧基苯磺酰氯(4);再以甘氨酸、苄醇、邻硝基苯甲酰氯为原料经酯化、酰氨化、还原得到N-(2-氨基苯甲酰基)甘氨酸苄酯(7);将4和7两中间体缩合得1。结果及结论本方法原料廉价易得,条件温和易控,收率较高,适合工业化生产。 Aim To synthesize the key intermediate of sivelestat sodium, N-[2-(4-trimethylacetoxybenzenesulphonamino)benzoyl]glycine benzyl ester. Method Trimethylacetic acid, thionyl chioride and p-hydroxybenzenesulfonic acid was treated by esterification, sulfonyl chloride formation to give trimethylacetoxybenzenesulfonic chloride (4). Glycine, benzyl alcohol and o-nitrobenzoyl chloride was treated by esterification, acylamination and reduction to give N- (2-aminobenzoyl) glycine benzyl alcohol ester (7). The target compound was obtained by condensation between (4) and (7). Results and conclusion The raw materials in this route is cheap, and the reaction condition is easy to control. Yield is higher and this method can be applied in industry production.
出处 《中国药物化学杂志》 CAS CSCD 2006年第2期79-81,111,共4页 Chinese Journal of Medicinal Chemistry
关键词 药物化学 化合物制备 化学合成 N-[2-(4-特戊酰氧基苯磺酰胺基)苯甲酰基]甘氨酸苄酯 西维来司钠 medicinal chemistry compound preparation chemical synthesis N-[2-( 4 trimethylacetoxybenzenesulphonamino)benzoyl]glycine benzyl ester sivelestat sodium
  • 相关文献

参考文献6

  • 1Prous J,Graul A,Castaner J.Ono-5046[J].Drugs Future,1994,19(11):1000-1002.
  • 2Imaki K,Minase R,Wakatsuka H,et al.Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase[P].EP:539223,1993-04-28(CA 1993,119:18226x).
  • 3章思规,章伟.精细化学品及中间体手册(下卷)[M].北京:化学工业出版社,2004:1765-1766.
  • 4Imaki K,Arai Y,Okegawa T.Derivatives of p-substituted phenyl ester of pivalic acid[P].EP:347168,1989-12-20 (CA 1990,113:114810w).
  • 5李伟,卞红平,宁奇.西维来司钠的合成[J].化学世界,2004,45(1):29-31. 被引量:7
  • 6黄伟,吴雪松,岑均达.西维来司钠的合成[J].中国医药工业杂志,2003,34(8):369-370. 被引量:4

二级参考文献8

  • 1[1]Kawabata K, Suzuki M, Sugitani M, et al. Ono5046, a novel inhibitor of human neutrophil elastase [J]. Biochem Biophys Res Commun, 1991,177 (2):814-820.
  • 2[2]Zeiher B G, Matsuoka S, Kawabata K, et al. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics [J]. Crit Care Med, 2002,30 (5 Suppl ):S281-S287.
  • 3[3]Katsuhiro I, Yoshinobu A, Tadao O. Preparation of p-substituted phenyl ester of pivalic acid elastase inhibitor and pharmaceutical compositions[P]. EP:347168,1989-12-20. (CA 1990,133:114810w)
  • 4[4]Katsuhiro I, Hirohisa W. Preparation of an acylglycine derivative as an elastase inhibitor[P]. EP:539 223,1993-04-28. (CA 1993,119:181226x)
  • 5[5]Taschner E, Wasielewski G. New esterification procedures in peptide chemistry[J]. Ann, 1961,640,136-139.
  • 6Katsuhiro I, Hirohisa W. Preparation of an acylglyeine derivative as an elastase inhibitor [P]. EP:539223,1993-04-28. (CA 1993,119:181226x).
  • 7Katsuhiro I, Yoshinobu A, Tadao O. Preparation of p-substituted phenyl ester of pivalic acid as elastase inhibitor and pharmaceutical compositions [P]. EP:347168,1989-12-20. (CA 1990,113:114810w).
  • 8The Merck Index[M]. 13th ed, 8629.

共引文献10

同被引文献11

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部